Twenty-nine states sued Bristol-Myers Squibb Co. on Tuesday, accusing the maker of the cancer drug Taxol of fraudulently keeping less-expensive generic versions off the market. The suit alleged that the pharmaceutical company obtained patents for Taxol under false pretenses and delayed generic versions from coming on to the market, forcing hospitals, patients and states to pay more for the medicine.
June 05, 2002 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
Women Leaders in Consulting Awards honors the industry standouts and rising stars who are making a mark within the profession.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
General Statement of DutiesPerforms legal work involving full litigation of all types of matters both for and against the Town, including al...
Shipman & Goodwin LLP is seeking a attorney to expand our national commercial real estate lending practice. Candidates should have a mi...
Health Law Associate CT Shipman is seeking an associate to join our national longstanding health law practice. Candidates must have t...
